state California Progressive Gilead GILD patient medicines state California

Gilead drops 11% after lung cancer drug trial fails, analysts say stock is 'overreacting'

Reading now: 622
investing.com
The website fvbb.com is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.
DMCA